2008 - 2010
Development of new therapeutic agents for brain tumor using protein therapy
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (A) Grant-in-Aid for Scientific Research (A)
- Grant number
- 20249009
- Japan Grant Number (JGN)
- JP20249009
- Grant amount
-
- (Total)
- 50,050,000 Japanese Yen
- (Direct funding)
- 38,500,000 Japanese Yen
- (Indirect funding)
- 11,550,000 Japanese Yen
Boron neutron capture therapy (BNCT) is a novel cancer treatment modality that can selectively target the tumor without causing excessive radiation damage to the normal tissues. In this project, we developed 2 types of new therapeutic agents for BNCT : cell-penetrating peptides using the protein therapy or nanoparticles, which are effective of delivering cargo into cells, to deliver ^<10>B into the tumor cells as BNCT agents. In both in-vitro studies using the cultured tumor cells and in-vivo studies using tumor-bearing mice, these agents were only observed in the tumor. The results suggest that our systems utilizing peptides or nanoparticles provide an effective means of delivering ^<10>B into tumor cells selectively in BNCT.
- Link information
- ID information
-
- Grant number : 20249009
- Japan Grant Number (JGN) : JP20249009
List of results of the research project
Narrowing down
Presentations
7-
The 3rd Neutron Therapy Research Center Symposium, Dec 10, 2019
-
SickKids Hospital Reserch meeting organized by the Labatt Brain Tumor Research Centre, Nov 27, 2019 Invited
-
10th Young Researchers BNCT meeting, Sep 26, 2019
-
2nd synposium of Neutron Therapy Research Center in Okayama University, Dec 12, 2018 Invited
-
Symposium of metal bioscience 2017, Oct 14, 2017 Invited
-
第14回日本中性子捕捉療法学会学術大会, Sep 29, 2017
-
The 25th America Peptide Symposium, Jun 19, 2017